The Swedish drug from Covid-19 is already in the capital city

On Saturday, March 13, AstraZeneca-SKBio coronavirus vaccine was delivered to the capital of Georgia.

A total of 43.2 thousand doses. The Swedish drug was developed in cooperation with Oxford, and produced at a South Korean facility.

Within two days, the vaccine will be distributed to the regions and then to medical institutions where vaccination is expected to be carried out.

More than 80 clinics have been selected and approved by the National Center for Disease Control for Georgia.

to rate this post.

Related articles

  1. Step-by-step plan for lifting covid restrictions provided by Georgian Prime Minister Irakli Garibashvili

  2. Cancellation of restrictions in Georgia from mid-March

  3. The rate of mask wearing has decreased in Georgia. The risk of a third wave of Covid-19. Opinion of infectious disease specialists

  4. Children's entertainment complexes will resume operations in 14 days

  5. Will curfews be lifted by the end of the month?

By categories

1 comment

Log in to leave a comment

  • M
    mamontov3572
    Шведский препарат AstraZeneca действительно вызывает доверие, ведь он разработан в сотрудничестве с Оксфордом и произведён на южнокорейском предприятии. Насколько мне известно, этот препарат одобрен Всемирной Организацией Здравоохранения. То, что в новости говорится о распространении вакцины по регионам Грузии и последующей вакцинации населения, действительно даёт большие надежды на победу над коронавирусом.